Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Reunion Industry Brief.
National Personal Chef Day Spotlights a $16.88B Industry Transforming Luxury Dining at Home
On National Personal Chef Day, a $16.88B industry redefines luxury platforms like Chef2Nite turn home dining into bespoke, unforgettable experiences. MIAMI , FL, UNITED STATES, July 16, 2025 /EINPresswire.com/ -- As Americans increasingly seek...
Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
Saint Herblain (France), April 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its recommendation...
Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion
Saint Herblain (France), March 24, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La Réunion...
Renowned vocalist and songwriter TERRY ILOUS unveils his latest single and Music Video 'Mentiras' September 30th
LOS ANGELES, CA, UNITED STATES, September 24, 2025 /EINPresswire.com/ -- TERRY ILOUS, hit recording artist and founding member of 80's rock band XYZ makes another big splash in the entertainment industry as he carries his music to a new era, and...
EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book
Introduction The European Central Bank (ECB), with the support of the European System of Central Bank’s (ESCB’s) Statistics Committee, compiles and publishes the balance of payments (b.o.p.) and the international investment position (i.i.p.) of...
Owner: European Union
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance - Publication of Circular for Combined Annual General Meeting of September 30, 2025
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance Publication of Circular for Combined Annual General Meeting of September 30, 2025 Nantes, September 9, 2025, 8:30 p.m. CET - OSE Immunotherapeutics SA...
Deputy President Shipokosa Paulus Mashatile: Heritage Day 2025
Programme Directors, Minister of Sport, Arts, and Culture, Mr. Gayton McKenzie and Deputy Minister of Sport, Arts and Culture, Ms. Peace Mabe; Honourable Ministers and Deputy Ministers present here today; Members of Parliament and Provincial...
Owner: South African Government
Statement on the Cabinet meeting of Wednesday, 17 September 2025
A. Issues in the environment 1. Economy 1.1. Economic Growth 1.1.1. Cabinet welcomed the latest GDP figures, which show that the economy has grown 0.8% in the second quarter of 2025, an improvement from the 0.1% growth in the first quarter. 1.1.2....
Owner: South African Government
Bloomin' Blinds of BuxMont Is 2025 Franchise Owner of the Year at National Awards Event
Bloomin’ Blinds of BuxMont earns top franchise honors and national sales awards at 2025 Bloomin’ Blinds Family Reunion and Pink Party. SOUTHAMPTON, PA, UNITED STATES, July 30, 2025 /EINPresswire.com/ -- At the 2025 Bloomin’ Blinds Awards...
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Saint Herblain (France), August 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the United States Food and Drug Administration (FDA) has suspended the license for IXCHIQ®, citing four...
WHO cautions against increase of chikungunya illness
(MENAFN) The World Health Organization (WHO) has warned on Tuesday that without swift measures, the world risks facing a resurgence similar to the 2005 chikungunya outbreak. “Although chikungunya is not widely recognized, it is currently present...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
Total revenues of €97.6 million compared to €70.8 million in the first half of 2024 Cash and cash equivalents of €161.3 million at end of June 2025 Further clinical and regulatory progress 2025 financial outlook confirmed Saint-Herblain (France),...
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Saint Herblain (France), August 7, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of age and older...
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®
IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels remained high after six months in both dose groups, although more robust with the full dose Six-month...
NY Rum Fest & Conference takes place in Brooklyn on June 7th
Celebrating its 9th anniversary, New York Rum Fest continues with its core goal to promote rum education and premiumization. NEW YORK, NY, UNITED STATES, May 26, 2025 /EINPresswire.com/ -- Returning to NYC for its ninth year on Saturday, June...
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
Saint Herblain (France), May, 12 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Association (FDA) and the U.S. Centers for Disease Control and Prevention (CDC), in a...
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
Saint Herblain (France), May, 07 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) has started a review of Valneva’s single-dose live attenuated chikungunya...
Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers
Saint Herblain (France), April 18, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that during its regular meeting on April 16, the U.S. Centers for Disease Control and Prevention’s (CDC)...